Accessibility Menu
 
Avicanna logo

Avicanna

(OTC) AVCNF

Current Price$0.11
Market Cap$14.31M
Since IPO (2019)-96%
5 Year-87%
1 Year-34%
1 Month-19%

Avicanna Financials at a Glance

Market Cap

$14.31M

Revenue (TTM)

$25.47M

Net Income (TTM)

$2.93M

EPS (TTM)

$-0.02

P/E Ratio

-6.36

Dividend

$0.00

Beta (Volatility)

0.64 (Low)

Price

$0.11

Volume

40,000

Open

$0.11

Previous Close

$0.11

Daily Range

$0.11 - $0.11

52-Week Range

$0.10 - $0.24

AVCNF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Avicanna

Industry

Pharmaceuticals

Employees

80

CEO

Aras Azadian, MBA

Headquarters

Toronto, ON M5G 1V2, CA

AVCNF Financials

Key Financial Metrics (TTM)

Gross Margin

52%

Operating Margin

-11%

Net Income Margin

-12%

Return on Equity

-112%

Return on Capital

-23%

Return on Assets

-14%

Earnings Yield

-15.72%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$14.31M

Shares Outstanding

125.68M

Volume

40.00K

Short Interest

0.00%

Avg. Volume

41.37K

Financials (TTM)

Gross Profit

$12.83M

Operating Income

$2.71M

EBITDA

$1.97M

Operating Cash Flow

$1.18M

Capital Expenditure

$255.66K

Free Cash Flow

$1.44M

Cash & ST Invst.

$280.40K

Total Debt

$0.00

Avicanna Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$6.59M

-0.3%

Gross Profit

$3.49M

+1.2%

Gross Margin

52.93%

N/A

Market Cap

$14.31M

N/A

Market Cap/Employee

$164.49K

N/A

Employees

87

N/A

Net Income

$924.52K

-803.0%

EBITDA

$619.23K

-279.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$280.40K

-17.2%

Accounts Receivable

$3.54M

+28.9%

Inventory

$3.85M

-3.3%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-13.81%

N/A

Return on Invested Capital

-22.90%

N/A

Free Cash Flow

$198.77K

+63.7%

Operating Cash Flow

$190.90K

+20.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CNTMFFluent Corp.
$0.03+0.00%
VYYRFVoyageur Pharmaceuticals Ltd.
$0.09+0.00%
IZOZFIzotropic Corporation
$0.17+7.66%
MEDIFMediPharm Labs Corp.
$0.05+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.47+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$49.60+0.01%
EOSEEos Energy Enterprises
$5.84-0.02%
VALEVale
$17.07+0.02%

Questions About AVCNF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.